Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit From Olaparib
Oncologist - United States
doi 10.1634/theoncologist.2019-0393
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2019
Authors
Publisher
Alphamed Press